172 related articles for article (PubMed ID: 7695317)
1. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.
van Zwet AA; Thijs JC; de Graaf B
Antimicrob Agents Chemother; 1995 Jan; 39(1):250-2. PubMed ID: 7695317
[TBL] [Abstract][Full Text] [Related]
2. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Ling TK; Cheng AF; Sung JJ; Yiu PY; Chung SS
Helicobacter; 1996 Mar; 1(1):57-61. PubMed ID: 9398914
[TBL] [Abstract][Full Text] [Related]
3. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
Roghani HS; Massarrat S; Pahlewanzadeh MR; Dashti M
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):709-12. PubMed ID: 10445787
[TBL] [Abstract][Full Text] [Related]
4. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
[TBL] [Abstract][Full Text] [Related]
5. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.
Andersen LP; Colding H; Kristiansen JE
Int J Antimicrob Agents; 2000 Apr; 14(3):231-4. PubMed ID: 10773493
[TBL] [Abstract][Full Text] [Related]
7. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
8. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
[TBL] [Abstract][Full Text] [Related]
10. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
11. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
[TBL] [Abstract][Full Text] [Related]
13. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
Midolo PD; Lambert JR; Turnidge J
J Gastroenterol Hepatol; 1996 Mar; 11(3):290-2. PubMed ID: 8742929
[TBL] [Abstract][Full Text] [Related]
14. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
Coudron PE; Stratton CW
J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
[TBL] [Abstract][Full Text] [Related]
15. New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.
Xie Y; Pan X; Li Y; Wang H; Du Y; Xu J; Wang J; Zeng Z; Chen Y; Zhang G; Wu K; Liu D; Lv N
J Antimicrob Chemother; 2018 Jun; 73(6):1681-1687. PubMed ID: 29596646
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication therapy in The Netherlands.
Houben MH; van de Beek D; Hensen EF; de Craen AJ; van 't Hoff BW; Tytgat GN
Scand J Gastroenterol Suppl; 1999; 230():17-22. PubMed ID: 10499457
[TBL] [Abstract][Full Text] [Related]
17. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population.
López-Brea M; Martínez MJ; Domingo D; Sánchez I; Alarcón T
FEMS Immunol Med Microbiol; 1999 Jun; 24(2):183-8. PubMed ID: 10378418
[TBL] [Abstract][Full Text] [Related]
19. Role of Bismuth in the Eradication of Helicobacter pylori.
Alkim H; Koksal AR; Boga S; Sen I; Alkim C
Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
[TBL] [Abstract][Full Text] [Related]
20. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
